EUSA Pharma宣佈FDA核准Silvoximab治療COVID-19相關急性呼吸窘迫症候群住院病患的第3期臨床試驗

View Full Size 

Download

• Full Size JPEG, 1024x219, 23.1 KB
• Small JPEG, 480x103, 7.8 KB
• Preview JPEG, 144x31, 1.7 KB
• Thumbnail JPEG, 120x26, 1.3 KB